AzTrials
AzTrials

The Usefulness of Specific Scores in Predicting Mortality of Patients With Head Trauma in ICUNCT06922396

Predictors of Mortality Among Patients With Head Trauma

An observational study of The Usefulness of Specific Scores in Predicting Mortality of Patients With Head Trauma in ICU, run by Ayman Mahmoud Alsayes at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Evaluate the usefulness of the APACHE II (Acute Physiology and Chronic Health Evaluation II), RTS (Revised trauma score), GCS (Glasgow Coma Scale) scores and various variables as age, sex, lab.data and complications in predicting mortality of patients with traumatic brain injury (TBI) in the intensive care unit (ICU). Read more about this study

Who is it for?
Ages 16 to 75 years
What is being tested?
Parameters on admission
How many people
140 participants
Where
1 siteEgypt
Study dates
1 Jun 2024to 20 Jun 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 75 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: 140 patients admitted to I.C.U during the period of the study, all the studied populations will diagnosed to have an acute traumatic brain injury (TBI).

Who may be able to join

  • All patients with acute traumatic brain injury older than 16 years where presented in emergency department within 24 hours of trauma with a Glasgow coma scale less than 15

Who cannot join

  • o Post cardiac arrest
  • Patients with GCS=3.
  • Patients with associated advanced cervical spine, maxillofacial, severe chest trauma.
  • Patients with previous neurological disorders

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayman Mahmoud Alsayes, Master contact

00201010283811

draymanalsayes@gmail.com

Egypt1 site, 1 recruiting
  • Faculty Of Medicine , Ain Shams University

    Cairo

    faculty of medicine, 20226857539, REC-FMASU@med.asu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Evaluate the usefulness of the APACHE II (Acute Physiology and Chronic Health Evaluation II), RTS (Revised trauma score), GCS (Glasgow Coma Scale) scores and various variables as age, sex, lab.data and complications in predicting mortality of patients with traumatic brain injury (TBI) in the intensive care unit (ICU).

Read the detailed description

Head injuries are a major cause of morbidity and mortality through out the world. It is estimated that 69 million people suffer from Traumatic Brain Injury (TBI) from all cases per year .

Current estimates suggest that about 4.48 million people lose their lives due to injuries which accounts for 8% of all deaths globally. Of these, an estimated 2 million deaths were attributed to the TBI, and the burden was concentrated in developing countries due to limited access to advanced life-sustaining measures after trauma .

In low-and middle-income countries, head injury patients have worse outcomes than patients in high-income countries . Several studies in Africa have found that death rates from head injury range from 4.2% to 35% .

Evidence suggests that the possible causes for the high mortality rate could be older age, male gender,low GCS, and cause of injuries are likely non-modifiable risk factors and hypoxia, hypotension, hyperthermia, hypo or hyperglycemia, and did not undergo surgery or poor adherence to management guidelines are possible modifiable risk factors .

Clinical presentation of patients and advanced rescue care by emergency teams are crucial factors to determining favorable outcomes. Accordingly, non-surgical management should emphases on rapid transportation, avoiding hypotension and hypoxia, hyperthermia, and medical management to reduce brain edema .

Accurate determination of the prognosis is crucial for the practitioners, in order to optimize and personalize treatment strategies. There is a degree of uncertainty in clinicians' expectations of patient outcomes, and prognostic models can help improve these expectations by providing probabilities of specific outcomes. Compared with the experience of physicians to judge the prognosis of patients, objective prognostic models would be able to give more accurate projections about specific variables such as number of hospitalizations and deaths .

The predictors of mortality modules used are GCS, APACHE II and RTS scores. GCS provides an objective recording of the state of consciousness of a person, which is the only variable referring to brain function in the APACHE II score. APACHE II score was primarily designed to predict mortality in ICUs. The famous models: the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) model and the Corticosteroid Randomization After Significant Head Injury (CRASH) model were weighted towards mixed TBI (moderate and severe TBI).

The management of TBI patients should be followed intracranial pressure monitoring is suggested to reduce post-traumatic death in the hospital within two weeks .

Unfortunately, pre hospital care is not well established and hospitals are not well equipped;this can increase the risk of secondary brain injury due to hypotension and hypoxia .

Being tested
Parameters on admission

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parameters on admissionOther

    Also called Parameters after 2 weeks

    A: Parameters on admission:

    • Age.
    • Sex.
    • Comorbidities (DM, HTN, CKD, IHD, Liver Disease)
    • Mode of trauma.
    • Laboratory data (RBS, INR, AST, ALT, Urea, Creatinine, WBC ,HB, CK, Myoglobin).
    • Ct brain findings.
    • Scoring system (GCS, RTS, APACHE II).

    B: Parameters after 2 weeks:

    • Days on Mechanical Ventilation.
    • Medical or surgical management.
    • Complications (Pneumonia, DVT, septic shock, Pulmonary embolism, ARDS).
Study groups in NCT06922396
Study groupRoleWhat they receive
Survivors groupNot described
Receives: Other: Parameters on admission
Non survivors groupNot described
Receives: Other: Parameters on admission

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The studied patients will be observed for 1 month and mortality will be recorded.

    Measured: average 6 to 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2025
  2. Study start1 Jun 2024
  3. Primary completion1 May 2025 (estimated)
  4. Study completion20 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06922396
Sponsor's protocol ID
Mortality prediction in TBI
Status last verified
Apr 2025
First submitted
3 Apr 2025
Last updated
10 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of The Usefulness of Specific Scores in Predicting Mortality of Patients With Head Trauma in ICU, run by Ayman Mahmoud Alsayes at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayman Mahmoud Alsayes, Master (00201010283811, draymanalsayes@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The studied patients will be observed for 1 month and mortality will be recorded. (time frame: average 6 to 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in